Drug application
CIPROFLOXACIN EXTENDED RELEASE (CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE)
Drugs@FDA ANDA 078712 · FOSUN PHARMA
Key facts
| Drug name | CIPROFLOXACIN EXTENDED RELEASE |
|---|---|
| Active ingredients | CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 078712 |
| Company | FOSUN PHARMA |
| Dosage forms | TABLET, EXTENDED RELEASE, ORAL |
| Strength | 212.6MG;EQ 287.5MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Dec 11, 2007 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: